Table 1.
Descriptive statistics of subjects by baseline glycemic status at CRISPS1 (N = 2649).
Data was present as mean±SD or median (interquartile range); *Log-transformed before analysis. BMI, body mass index; WC, waist circumference; WHR, waist-hip-ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; HT, hypertension; FG, fasting glucose; 2hG, 2-hour glucose post OGTT; HOMA-IR, Homeostasis Model Assessment-Insulin Resistance; NGT, normal glucose tolerance; T-Chol, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; LDL-C; low density lipoprotein cholesterol.
Table 2.
Correlation of baseline clinical and biochemical parameters with successive HOMA-IR quartiles at CRISPS1 (N = 2649).
Data was present as means±SD or medians (interquartile range).
Fig 1.
The receiver-operating characteristic curves of baseline HOMA-IR for detecting dysglycemia (dotted line) or type 2 diabetes (solid line).
Table 3.
Optimal cut‐off points for baseline HOMA-IR to discriminate dysglycemia from normal glucose tolerance, or type 2 diabetes from non-diabetes, at baseline (N = 2649).
Table 4.
Reference range of HOMA-IR derived from the persistent NGT group* (N = 872).